CA Patent

CA2812043A1 — Pyrimidinedione anti-viral compounds

Assigned to Kineta Inc · Expires 2011-10-27 · 15y expired

What this patent protects

Disclosed herein are compounds and related compositions for the treatment of viral infection, including RNA viral infection, and compounds that can modulate the RIG- I pathway in vertebrate cells, including compounds that can activate the RIG-I pathway.

USPTO Abstract

Disclosed herein are compounds and related compositions for the treatment of viral infection, including RNA viral infection, and compounds that can modulate the RIG- I pathway in vertebrate cells, including compounds that can activate the RIG-I pathway.

Drugs covered by this patent

Patent Metadata

Patent number
CA2812043A1
Jurisdiction
CA
Classification
—
Expires
2011-10-27
Drug substance claim
No
Drug product claim
No
Assignee
Kineta Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.